4Filing Date: Sep 10, 2026

Metlife

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001754648-26-000013
Total Value$15.0K
Trades1
Insiders1

Transaction Details

MCKENZIE DIANA
Director·Direct
Grant · Acquire
Common Stock
Shares+157
Price$95.50
Total Value$15.0K
Shares Owned After25.39K
Transaction DateSep 8, 2026
Footnotes ▸

Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Post-Transaction Holdings

MCKENZIE DIANA · Director
SecuritySharesChange
Common Stock25.39K+157 (0.62%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-08 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: METLIFE INC (MET) CIK: 0001099219 --- Reporting Owner --- Name: MCKENZIE DIANA CIK: 0001754648 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-08 | Code: A (Grant or award) Shares: +157 | Price: $95.50 Total Value: $14,993.50 Shares Owned After: 25,385 | Ownership: D (Direct) Footnotes: [F1] Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. --- Footnotes (Complete Index) --- F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. --- Signature --- /s/ /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact (2026-09-10)

keid analysis is for reference only and does not constitute investment advice.